Plain-English translation of NCT06106477 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This small study is looking at whether intermittent fasting—eating only during a 10-hour window each day and fasting for 14 hours overnight—might help women with hormone receptor positive, HER2-negative breast cancer who are starting long-term hormone-blocking therapy. The researchers want to see if this eating pattern is something women can realistically stick with, and whether it might improve quality of life and reduce inflammation in the body.
Many breast cancer survivors struggle with weight gain and inflammation during hormone therapy, which can affect how they feel and their overall health. This study wants to explore whether a simple fasting routine could be an easy, supportive tool to help manage these side effects.
You likely qualify if…
You likely don't qualify if…
You would commit to fasting for 14 hours each night and eating during a 10-hour window during the day for six months. The study will track how well you can stick with this routine and measure changes in your quality of life, body measurements, and blood markers of inflammation. You'll likely have visits at the start, during, and at the end of the six months to check in and provide blood samples.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
United States